CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011
Revenues	$ 382,264	$ 495,423	$ 1,380,787	$ 1,615,096
Cost of Goods Sold	371,941	361,017	1,119,850	1,035,663
Gross Profit	10,323	134,406	260,937	579,433
Research and Development Expenses, net	198,608	163,672	498,842	637,259
Selling, General and Administrative Expenses	309,913	264,493	837,987	724,923
Gain on Sale of Assets and Other	(7,308)	(6,443)	(9,457)	(36,434)
Total Operating Expenses	501,213	421,722	1,327,372	1,325,748
Operating Loss	(490,890)	(287,316)	(1,066,435)	(746,315)
Gain on Sale of Patents			2,276,286
Interest Income	1	4	534	206
Interest Expense	(1,250)	(15,000)	(28,958)	(45,000)
Net Income (Loss)	$ (492,139)	$ (302,312)	$ 1,181,427	$ (791,109)
Income (Loss) Per Share:
Basic (in Dollars per share)	$ (0.40)	$ (0.31)	$ 1.04	$ (0.79)
Diluted (in Dollars per share)	$ (0.40)	$ (0.31)	$ 0.97	$ (0.79)
Weighted Average Common Shares Outstanding:
Basic (in Shares)	1,245,339	971,013	1,135,432	1,002,669
Diluted (in Shares)	1,245,339	971,013	1,243,527	1,002,669